# Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis

> **NCT00967941** · — · COMPLETED · sponsor: **CAMC Health System** · enrollment: 169 (actual)

## Conditions studied

- MRSA Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00967941
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-06
- **Final completion:** 2010-08
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2020-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967941, "Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00967941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*